PAX Financial Group’s iShares Biotechnology ETF IBB Stock Holding History

PAX Financial Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$374K	Hold	2,213	–	–	0.06%	146
2025 Q4	$373K	Hold	2,213	–	–	0.06%	159
2025 Q3	$319K	Sell	2,213 -579	-21%	-$79K	0.06%	177
2025 Q2	$353K	Sell	2,792 -208	-7%	-$25.5K	0.07%	174
2025 Q1	$384K	Hold	3,000	–	–	0.07%	191
2024 Q4	$397K	Hold	3,000	–	–	0.07%	188
2024 Q3	$437K	Hold	3,000	–	–	0.08%	181
2024 Q2	$412K	Hold	3,000	–	–	0.08%	187
2024 Q1	$412K	Hold	3,000	–	–	0.08%	186
2023 Q4	$403K	Hold	3,000	–	–	0.08%	183
2023 Q3	$367K	Hold	3,000	–	–	0.08%	179
2023 Q2	$381K	Hold	3,000	–	–	0.09%	172
2023 Q1	$387K	Hold	3,000	–	–	0.09%	165
2022 Q4	$394K	Hold	3,000	–	–	0.1%	149
2022 Q3	$351K	Hold	3,000	–	–	0.09%	151
2022 Q2	$353K	Hold	3,000	–	–	0.09%	146
2022 Q1	$391K	Hold	3,000	–	–	0.09%	157
2021 Q4	$458K	Hold	3,000	–	–	0.1%	141
2021 Q3	$485K	Hold	3,000	–	–	0.12%	132
2021 Q2	$491K	Hold	3,000	–	–	0.12%	126
2021 Q1	$452K	Hold	3,000	–	–	0.13%	115
2020 Q4	$454K	Hold	3,000	–	–	0.14%	100
2020 Q3	$406K	Hold	3,000	–	–	0.14%	104
2020 Q2	$410K	Hold	3,000	–	–	0.16%	89
2020 Q1	$379K	Sell	3,000 -114	-4%	-$13.1K	0.16%	85
2019 Q4	$382K	Buy	+3,114	New	+$347K	0.16%	64

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PAX Financial Group's IBB Position: Q1 2026 in Review

PAX Financial Group held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 2,213 shares worth $374K. The position accounts for 0.06% of the portfolio, ranked #146.

PAX Financial Group first reported a position in IBB in Q4 2019 and has held it in 26 quarters since. The position peaked at $491K in Q2 2021. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

PAX Financial Group held 2,213 shares of iShares Biotechnology ETF worth $374K as of Q1 2026.
PAX Financial Group left its iShares Biotechnology ETF share count unchanged in Q1 2026.
iShares Biotechnology ETF made up 0.06% of PAX Financial Group's portfolio in Q1 2026, its #146 holding.
PAX Financial Group first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 26 quarters since.
PAX Financial Group's iShares Biotechnology ETF position peaked at $491K in Q2 2021.
919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on PAX Financial Group's 13F filing for Q1 2026, filed 27 Apr 2026.